Orthopedic companies are developing ecosystems with enabling technology and digital tools used for pre-, intra- and post-operative patient care. Surgical planning, navigation and robotics aim to bring proficiency and preciseness to orthopedic procedures, while wearables and apps focus on patient monitoring and education. The technologies are feeding data that could have an immense impact on patient care. This panel discussion includes orthopedic companies with varying types of enabling and digital technologies. The group explores questions such as: What are the uses and benefits of the technology today? How will the technology advance over time? How will data be captured and utilized to improve technology, surgical techniques and patient outcomes? What will it take to gain greater adoption in orthopedics? What role do ethics play in technology’s future?
Michael Evers is a Senior Market Analyst and writer at ORTHOWORLD. He leads the development of ORTHOWORLD’s proprietary revenue models, covers industry trends and co-authors THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT. Before joining ORTHOWORLD in 2018, Mr. Evers served in analyst roles within the cardiac rhythm management and physician practice management industries.
Kevin Hykes is the President and CEO of Augmedics and an accomplished medical device industry executive with 30 years of experience. Prior to joining Augmedics, Mr. Hykes was President and CEO of Bardy Diagnostics, a provider of ambulatory cardiac monitoring and digital health solutions which was acquired by the Hillrom Corporation in August of 2021. Before Bardy Diagnostics, Mr. Hykes served in President and CEO roles at Relievant Medsystems, Metavention, Inc. and Cameron Health. Mr. Hykes also spent over sixteen years at Medtronic, where he held leadership positions in the CRM, Neurostimulation and Cardiac Surgery businesses in the U.S. and Europe. He is currently an Operating Partner with Revival Healthcare Capital and an independent board member at CVRx Inc. (CVRX) and Metavention, Inc. Mr. Hykes received his MBA from Northwestern University and a BBA in Information Systems from the University of Wisconsin.
Kevin McGann is the President and CEO of Accelus. He previously served as Chief Commercial Officer of Accelus and its predecessor company Integrity Implants. Prior to this, Mr. McGann served as the President and Chief Executive Officer of Kallista Partners from 2017 to 2019. Additionally, Mr. McGann served as the Vice President of Sales of Stryker from 2015 to 2017. Mr. McGann holds a B.S. in Business Administration from Villanova University.
Edouard Saget is Co-Founder, Board Member and co-CEO of OrthoGrid Systems, and a healthcare entrepreneur with more than 20 years of experience developing and delivering market entry and growth initiative strategies for companies. He has broad experience working with hospital systems and physician-driven center of excellence programs, with a focus on digital integration to solve problems of efficiency and team engagement. Strategically minded and deploying processes around legal structure, intellectual property and fundraising, Mr. Saget has been critical in securing OrthoGrid’s patents and driving the development of proprietary technology. He attended Boise State University and the Universite de Medecine in France.